Clinical Trial Update: Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

View source ↗

Summary

The document describes an NCI study using whole exome sequencing to identify causative germline variants in patients with breast cancer who are receiving bevaci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Carcinoma | Status: RECRUITING